15710957

Source:http://linkedlifedata.com/resource/pubmed/id/15710957

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0009429, umls-concept:C0034656, umls-concept:C0209738, umls-concept:C0524909, umls-concept:C0556895, umls-concept:C2587213
pubmed:issue	4
pubmed:dateCreated	2005-2-15
pubmed:abstractText	Conventional interferon and lamivudine monotherapy are unsatisfactory in treating hepatitis B virus (HBV) infection.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/15710957-15710953, http://linkedlifedata.com/resource/pubmed/commentcorrection/15710957-16144900
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0372351
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Alanine Transaminase, http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents, http://linkedlifedata.com/resource/pubmed/chemical/DNA, Viral, http://linkedlifedata.com/resource/pubmed/chemical/Hepatitis B e Antigens, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha, http://linkedlifedata.com/resource/pubmed/chemical/Lamivudine, http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2b, http://linkedlifedata.com/resource/pubmed/chemical/peginterferon alfa-2b
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	1539-3704
pubmed:author	pubmed-author:ChanFrancis Ka-LeungFK, pubmed-author:ChanHenry Lik-YuenHL, pubmed-author:ChimAngel Mei-LingAM, pubmed-author:HuiAlex YuiAY, pubmed-author:HungLawrence Cheung-TsuiLC, pubmed-author:LamChristopher Wai-KeiCW, pubmed-author:LeeYuk-TongYT, pubmed-author:LeungNancy Wai-YeeNW, pubmed-author:LiewChoong-TsekCT, pubmed-author:SungJoseph Jao-YiuJJ, pubmed-author:TamJohn Siu-LunJS, pubmed-author:WongVincent Wai-SunVW
pubmed:issnType	Electronic
pubmed:day	15
pubmed:volume	142
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	240-50
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:15710957-Adolescent, pubmed-meshheading:15710957-Adult, pubmed-meshheading:15710957-Aged, pubmed-meshheading:15710957-Alanine Transaminase, pubmed-meshheading:15710957-Antiviral Agents, pubmed-meshheading:15710957-DNA, Viral, pubmed-meshheading:15710957-Drug Administration Schedule, pubmed-meshheading:15710957-Drug Therapy, Combination, pubmed-meshheading:15710957-Hepatitis B, Chronic, pubmed-meshheading:15710957-Hepatitis B e Antigens, pubmed-meshheading:15710957-Hepatitis B virus, pubmed-meshheading:15710957-Humans, pubmed-meshheading:15710957-Interferon-alpha, pubmed-meshheading:15710957-Lamivudine, pubmed-meshheading:15710957-Middle Aged, pubmed-meshheading:15710957-Polyethylene Glycols, pubmed-meshheading:15710957-Recombinant Proteins, pubmed-meshheading:15710957-Viral Load
pubmed:year	2005
pubmed:articleTitle	A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone.
pubmed:affiliation	Chinese University of Hong Kong and Alice Ho Miu Ling Nethersole Hospital, Hong Kong, China.
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Clinical Trial, Phase III